Abstract:Hepatitis B virus (HBV) infection is a common cause of liver diseases worldwide. Existing drugs do not effectively eliminate HBV from infected hepatocytes; thus, novel curative therapies are needed. Enveloped-particle secretion is a key but poorly studied aspect of the viral life cycle. Here, we report that GRP78 positively regulates HBV enveloped-particle secretion. GRP78 is the specific target of preS1 binding; HBV can upregulate GRP78 in liver cell lines and sera from chronic hepatitis B patients. GRP78 promoted intact HBV-particle secretion in liver cell lines and an HBV transgenic-mouse model. Some peptides screened from preS1 via phage display could inhibit viral-particle secretion by interacting with GRP78 via hydrogen bonds and hydrophobic interactions, thereby disturbing the interaction with HBV particles. These results provide insight into enveloped-particle secretion in the HBV life cycle. GRP78 might be a potential target for HBV-infection treatment via restricting GRP78–preS1 interactions to block viral-particle secretion.IMPORTANCE HBV is a major human pathogen. The virus More than 250 million n individuals globally are chronically infected with HBV and can result in the infected personsabout 800,000 die for HBV-related disease annually. The mature HBV enveloped particles containing HBs and the relaxed circular (RC) DNA genome could secreted extracellularly as virions. And these enveloped virions serves as the infectious HBV particles for initiating a complete life cycle of the virus. Here, we show the GRP78 is the specific target of preS1 binding, and it could positive regulate HBV enveloped particle secretion in cell and HBV transgenic mice model. Furthermore, several peptides screened from preS1 and Phage screening could inhibit viral particle secretion by interacting with GRP78 and disturbing its interaction with HBV, and then block the life cycle of the virus. This has important implications for our understanding of the mechanisms of antivirals that target intact HBV particles secretion.

Asialoglycoprotein Receptor Interacts with the Pres1 Domain of Hepatitis B Virus in Vivo and in Vitro

Identification and Characterization of Peptides That Interact with Hepatitis B Virus Via the Putative Receptor Binding Site.

Verification of the interaction between ASGPR and HBV preS1 protein

Intracellular localization and tissue distribution of HBV preS1 protein and ASGPR

NACA as a Potential Cellular Target of Hepatitis B Virus PreS1 Protein

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry.

Organ and Species Specificity of Hepatitis B Virus (HBV) Infection: a Review of Literature with a Special Reference to Preferential Attachment of HBV to Human Hepatocytes

Structural basis of hepatitis B virus receptor binding

Release of hepatitis B virions is positively regulated by glucose-regulated protein 78 through direct interaction with preS1.

Selection of HBV preS1 binding penta peptides by phage display

Research on cellular receptors associated with HBV preS 1 adhesion

Significance and Detection of PreS1 Envelope Antigen of Hepatitis B Virus (HBV)

HBV Enveloped Particle Secretion is Positively Regulated by GRP78 Through Direct Interaction with Pres1

Interaction of S17 Antibody with the Functional Binding Region of the Hepatitis B Virus Pre-S2 Epitope

[Transcriptional Activation Function of Hepatitis B Virus Pre S1 Protein in Yeast].

A Chemical Lipid Modification of Recombinant Pres Antigen to Study the Mechanism of HBV Attachment to the Host Cell

Affinity Purification of Hepatitis B Virus Surface Antigen Containing PreS1 Region.

Blocking peptides against HBV: preS1 protein selected from a phage display library.

Construction and Expression of HBV Pres1 Gene in Yeast

Identification of the Critical Regions in Hepatitis B Virus Pres Required for Its Stability

Efficient Inhibition of Hepatitis B Virus Infection by a Pres1-Binding Peptide